Formação Hormônios na Prática Médica · 2026
Todo artigo científico citado nos slides do FHPM, separado por aula, com link direto para o texto completo. Os artigos marcados em verde têm PDF liberado no PubMed Central e podem ser baixados sem assinatura.
Leitura crítica, desenhos de estudo e estatística aplicada
Pharmacokinetic analysis of 25 mg estradiol subcutaneous bioabsorbable implant in postmenopausal women (CLARA STUDY)
Compounded hormonal pellets: a critical review of current evidence and risks
Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial
Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity
Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults
Evidence based medicine: a movement in crisis?
Terapia hormonal, vias de administração, testosterona feminina
Testosterone Replacement Therapy in Women Is Associated with Improved Symptom Burden and Favorable Biomarker Changes: A Retrospective Observational Study
Cardiovascular mortality associated with testosterone therapy in cisgender women and transgender men: a systematic review
Subcutaneous Estradiol Pellets as Hormone Therapy in Menopause: Clinical Pharmacology, Patient Selection and Safety Considerations
Pharmacokinetic analysis of 25 mg estradiol subcutaneous bioabsorbable implant in postmenopausal women (CLARA STUDY)
Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes
Endometriosis During Peri-Menopause and Post-Menopause: A Review of the Literature
Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: national case-control study
Incidence of gynaecological (pre-)malignancies and endometrial activity in transmasculine and gender diverse individuals using testosterone: a retrospective, single-centre cohort study
Testosterone and pre-androgens by age and menopausal stage at midlife: findings from a cross-sectional study
Use of menopausal hormone therapy beyond age 65 years and its effects on women's health outcomes by types, routes, and doses
Mapping global prevalence of menopausal symptoms among middle-aged women: a systematic review and meta-analysis
The range and variation in serum estradiol concentration in perimenopausal and postmenopausal women treated with transdermal estradiol in a real-world setting: a cross-sectional study
Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study
Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms
New Light on Endometrial Thickness as a Risk Factor of Cancer: What Do Clinicians Need to Know?
Comparative venous thromboembolic safety of oral and transdermal postmenopausal hormone therapies among women Veterans
Over half of clinical practice guidelines use non-systematic methods to inform recommendations: A methods study
Menopausal Hormone Therapy and Cardiovascular Disease: The Role of Formulation, Dose, and Route of Delivery
The 2020 Menopausal Hormone Therapy Guidelines
Uterine fibroids in menopause and perimenopause
Progestogens in menopausal hormone therapy
Perimenopause as a neurological transition state
Guidelines: is bigger better? A review of SIGN guidelines
Lower Risk of Cardiovascular Events in Postmenopausal Women Taking Oral Estradiol Compared With Oral Conjugated Equine Estrogens
Abnormal Bleeding during Menopause Hormone Therapy: Insights for Clinical Management
Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women's Health Across the Nation (SWAN)
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications
Endometriose, adenomiose, SOP, miomas e TDPM
Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception
Effects of combined metformin and semaglutide therapy on body weight, metabolic parameters, and reproductive outcomes in overweight/obese women with polycystic ovary syndrome: a prospective, randomized, controlled, open-label clinical trial
Medical treatment of fibroids: FIGO best practice guidance
Semaglutide Alleviates Ovarian Oxidative Stress and Autophagy via the PI3K/AKT/mTOR Pathway in Mice with Polycystic Ovary Syndrome
Tolerability and Shared Decision-Making in the Hormonal Management of Endometriosis-Associated Pain
Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
Medical management of endometriosis
Premenstrual syndrome: new insights into etiology and review of treatment methods
The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
Myoinositol Versus Metformin in the Treatment of Polycystic Ovarian Syndrome: A Systematic Review
Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development
Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
The Main Theories on the Pathogenesis of Endometriosis
Diagnostic validity of premenstrual dysphoric disorder: revisited
Endometriosis-associated infertility: From pathophysiology to tailored treatment
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Life Modifications and PCOS: Old Story But New Tales
Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study
The evolutionary biology of endometriosis
Molecular and Cellular Insights into the Development of Uterine Fibroids
Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis
Genetic, Epigenetic, and Steroidogenic Modulation Mechanisms in Endometriosis
The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies
Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome
Molecular and Cellular Pathogenesis of Endometriosis
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
The pathophysiology of endometriosis and adenomyosis: tissue injury and repair
Diagnóstico, fisiopatogenia hormonal e tratamento
Unraveling lipedema: comprehensive insights and the path to future discoveries
Peritoneal Incretin Deficiency and Tirzepatide as a Multi-Axis Adjuvant Hypothesis in Treatment-Refractory Endometriosis: A Mechanistic Framework Linking Metabolism, Immunity, Fibrosis, and Nociception
Lipedema World Alliance Delphi Consensus-Based Position Paper on the Definition and Management of Lipedema: Results from the 2023 Lipedema World Congress in Potsdam
From Endometriosis to Lipedema: Toward a Neuroimmune Framework for Pain Amplification in Hormone-Sensitive Disorders
Lipedema and Dynapenia: Inflammatory Myosteatosis as a Mechanistic Link Between Tissue Expansion and Muscle Dysfunction
Lipedema in Women and Its Interrelationship with Endometriosis and Other Gynecologic Diseases: A Scoping Review
Lipedema as a hormone-sensitive stromal disorder: a four-pathway translational framework
New Characterization of Lipedema Stages: Focus on Pain, Water, Fat and Skeletal Muscle
A Case Series on the Efficacy of the Pharmacological Treatment of Lipedema: The Italian Experience with Exenatide
Tolerability and Shared Decision-Making in the Hormonal Management of Endometriosis-Associated Pain
Lipedema and adipose tissue: current understanding, controversies, and future directions
Tirzepatide as a Potential Disease-Modifying Therapy in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, and Fibrosis
The Expression of Adipogenic Marker Is Significantly Increased in Estrogen-Treated Lipedema Adipocytes Differentiated from Adipose Stem Cells In Vitro
The Role of Physical Exercise as a Therapeutic Tool to Improve Lipedema: A Consensus Statement from the Italian Society of Motor and Sports Sciences (Società Italiana di Scienze Motorie e Sportive, SISMeS) and the Italian Society of Phlebology (Società Italiana di Flebologia, SIF)
Proposed Framework for Research Case Definitions of Lipedema
What is the link between endometriosis and adiposity?
The Levels of Ghrelin, Glucagon, Visfatin and Glp-1 Are Decreased in the Peritoneal Fluid of Women with Endometriosis along with the Increased Expression of the CD10 Protease by the Macrophages
Adipose Tissue Dysfunction in Obesity: Role of Mineralocorticoid Receptor
Lipedema: Insights into Morphology, Pathophysiology, and Challenges
Obesity and risk of female reproductive conditions: A Mendelian randomisation study
Key signaling networks are dysregulated in patients with the adipose tissue disorder, lipedema
The Formidable yet Unresolved Interplay between Endometriosis and Obesity
Hormonal treatments for endometriosis: The endocrine background
Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
Aldo-Keto Reductase 1C1 (AKR1C1) as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema
The Genetic Background of Endometriosis: Can ESR2 and CYP19A1 Genes Be a Potential Risk Factor for Its Development?
Obesity and gynaecological and obstetric conditions: umbrella review of the literature
Rare adipose disorders (RADs) masquerading as obesity
Mioesteatose, diagnóstico e perda de função
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease
Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use
Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Effect of Bimagrumab on body composition: a systematic review and meta-analysis
Sarcopenic obesity in older adults: a clinical overview
Sarcopenic obesity: emerging mechanisms and therapeutic potential
Sarcopenic Obesity: Involvement of Oxidative Stress and Beneficial Role of Antioxidant Flavonoids
Proposal of definition and diagnostic criteria for sarcopenic obesity by ESPEN and EASO
Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis
Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management
Muscle Growth and Anabolism in Intensive Care Survivors (GAINS) trial: a pilot randomised controlled trial
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Anabolic-Androgenic Steroids and Exercise Training: Breaking the Myths and Dealing With Better Outcome in Sarcopenia
Food insecurity as a risk factor of sarcopenic obesity in older adults
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review
Sarcopenic obesity is associated with frailty among community-dwelling older adults: findings from the WCHAT study
The Role of Crosstalk between Adipose Cells and Myocytes in the Pathogenesis of Sarcopenic Obesity in the Elderly
Quality Matters as Much as Quantity of Skeletal Muscle: Clinical Implications of Myosteatosis in Cardiometabolic Health
The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN
Sarcopenic obesity
Effects of Testosterone and Progressive Resistance Exercise in Healthy, Highly Functioning Older Men With Low-Normal Testosterone Levels
Five-Year Outcomes after Oxandrolone Administration in Severely Burned Children: A Randomized Clinical Trial of Safety and Efficacy
Hipogonadismo, segurança cardiovascular e próstata
Oncological Safety of Testosterone Replacement Therapy in Men With a History of Prostate Cancer: A Systematic Review
Off-label testosterone therapy is associated with higher long-term cardiovascular risk in men
Metabolic Effects of Testosterone Replacement Therapy in Men with Functional Secondary Hypogonadism, Obesity and Type 2 Diabetes or Metabolic Syndrome: A Systematic Review
Testosterone Versus Clomiphene Treatment of Hypogonadism: A Retrospective Analysis in US Veterans
Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes
Approach to the Patient: Low Testosterone Concentrations in Men With Obesity
Effect of GLP-1 agonists on testosterone levels: a systematic review and meta-analysis
Effects of glucagon‐like peptide 1 receptor agonists on testicular dysfunction: A systematic review and meta‐analysis
The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation
Obesity Alters POMC and Kisspeptin Neuron Cross Talk Leading to Reduced Luteinizing Hormone in Male Mice
Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations
Low serum total testosterone level as a predictor of upgrading in low-risk prostate cancer patients after radical prostatectomy: A systematic review and meta-analysis
Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism
Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study
Low Testosterone Is Associated With Nonalcoholic Steatohepatitis and Fibrosis Severity in Men
Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study
Differential effects of 11 years of long-term injectable testosterone undecanoate therapy on anthropometric and metabolic parameters in hypogonadal men with normal weight, overweight and obesity in comparison with untreated controls: real-world data from a controlled registry study
Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials
Testosterone replacement therapy and hospitalization rates in men with COPD
Hypogonadotropic Hypogonadism in Men With Diabesity
Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men
Muscular responses to testosterone replacement vary by administration route: a systematic review and meta‐analysis
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance
Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial
Pharmacology of testosterone replacement therapy preparations
Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
Patient Satisfaction with Testosterone Replacement Therapies: The Reasons Behind the Choices
A Review of Testosterone Pellets in the Treatment of Hypogonadism
Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss
Incretinas, tirzepatida, semaglutida e novos alvos
Declining Bariatric Surgery Volumes and Shifting Practice Patterns: A Five-Year Analysis of Over One Million Procedures
Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity—2026
Muscle Strength, Genetic Risk, and Type 2 Diabetes Among Individuals of South Asian Ancestry: A UK Biobank Study
Retatrutide—A Game Changer in Obesity Pharmacotherapy
One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens
Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight
Forty Percent and Rising — Why Every Specialist Must Care about Obesity
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
The Role of Endocrine Disruptors Bisphenols and Phthalates in Obesity: Current Evidence, Perspectives and Controversies
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
Transforming obesity: The advancement of multi-receptor drugs
The effects of bupropion alone and combined with naltrexone on weight loss: a systematic review and meta-regression analysis of randomized controlled trials
The Effects of Tirzepatide on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial
Weight maintenance on cost‐effective antiobesity medications after 1 year of GLP‐1 receptor agonist therapy: a real‐world study
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
The Microbiota and Evolution of Obesity
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Probability of 5% or Greater Weight Loss or BMI Reduction to Healthy Weight Among Adults With Overweight or Obesity
Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)
Metaflammation in obesity and its therapeutic targeting
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
Selection of antiobesity medications based on phenotypes enhances weight loss: A pragmatic trial in an obesity clinic
Actigraphy-Derived Sleep Is Associated with Eating Behavior Characteristics
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity
Gut microbiota in obesity
Safety of Semaglutide
Endocrine-disrupting chemicals: implications for human health
Psychiatric Aspects of Obesity: A Narrative Review of Pathophysiology and Psychopathology
Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications
What Matters in Weight Loss? An In-Depth Analysis of Self-Monitoring
Sarcopenia, queimados, osteoporose e cuidados críticos
Nandrolone Decanoate for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Trials
Investigating the Role of Nandrolone Decanoate in the Management of Osteosarcopenia in Postmenopausal Women: A Prospective Observational Study
Sarcopenia prevention in older adults: Effectiveness and limitations of non-pharmacological interventions
Acute Sarcopenia: Mechanisms and Management
Mitigating disuse‐induced skeletal muscle atrophy in ageing: Resistance exercise as a critical countermeasure
The rate and assessment of muscle wasting during critical illness: a systematic review and meta-analysis
Muscle Growth and Anabolism in Intensive Care Survivors (GAINS) trial: a pilot randomised controlled trial
Anabolic-Androgenic Steroids and Exercise Training: Breaking the Myths and Dealing With Better Outcome in Sarcopenia
Over half of clinical practice guidelines use non-systematic methods to inform recommendations: A methods study
Role of anabolic testosterone agents and structured exercise to promote recovery in ICU survivors
Sarcopenia: revised European consensus on definition and diagnosis
Testosterone replacement therapy and hospitalization rates in men with COPD
Propranolol and Oxandrolone Therapy Accelerated Muscle Recovery in Burned Children
Left ventricular assist device for ventricular recovery of anabolic steroid-induced cardiomyopathy
Is sarcopenia associated with an increased risk of all-cause mortality and functional disability?
Anabolic steroids for treating pressure ulcers
FIVE-YEAR OUTCOMES AFTER LONG-TERM OXANDROLONE ADMINISTRATION IN SEVERELY BURNED CHILDREN
Winning the war against ICU-acquired weakness: new innovations in nutrition and exercise physiology
Muscle Mass Index As a Predictor of Longevity in Older Adults
Effect of Oral Anabolic Steroid on Muscle Strength and Muscle Growth in Hemodialysis Patients
Five-Year Outcomes after Oxandrolone Administration in Severely Burned Children: A Randomized Clinical Trial of Safety and Efficacy
Nenhuma referência encontrada.